| . | Receiving an SGLT2 inhibitor at baseline . | |
|---|---|---|
| Characteristics . | Yes (n = 267) . | No (n = 1317) . |
| eGFR (ml/min/1.73 m2), mean (SD) | 45.6 (15.7) | 46.8 (16.0) |
| eGFR category (ml/min/1.73 m2), n (%) | ||
| <25 | 10 (3.7) | 44 (3.3) |
| 25–<45 | 142 (53.2) | 642 (48.7) |
| 45–<60 | 64 (24.0) | 334 (25.4) |
| ≥60 | 47 (17.6) | 279 (21.2) |
| UACR (mg/g), median (IQR) | 871.9 (619.2–1409.1) | 808.3 (566.6–1218.5) |
| UACR category (mg/g), n (%) | ||
| <300 | 6 (2.2) | 57 (4.3) |
| 300–≤1000 | 148 (55.4) | 781 (59.3) |
| >1000 | 113 (42.3) | 479 (36.4) |
| . | Receiving an SGLT2 inhibitor at baseline . | |
|---|---|---|
| Characteristics . | Yes (n = 267) . | No (n = 1317) . |
| eGFR (ml/min/1.73 m2), mean (SD) | 45.6 (15.7) | 46.8 (16.0) |
| eGFR category (ml/min/1.73 m2), n (%) | ||
| <25 | 10 (3.7) | 44 (3.3) |
| 25–<45 | 142 (53.2) | 642 (48.7) |
| 45–<60 | 64 (24.0) | 334 (25.4) |
| ≥60 | 47 (17.6) | 279 (21.2) |
| UACR (mg/g), median (IQR) | 871.9 (619.2–1409.1) | 808.3 (566.6–1218.5) |
| UACR category (mg/g), n (%) | ||
| <300 | 6 (2.2) | 57 (4.3) |
| 300–≤1000 | 148 (55.4) | 781 (59.3) |
| >1000 | 113 (42.3) | 479 (36.4) |
| . | Receiving an SGLT2 inhibitor at baseline . | |
|---|---|---|
| Characteristics . | Yes (n = 267) . | No (n = 1317) . |
| eGFR (ml/min/1.73 m2), mean (SD) | 45.6 (15.7) | 46.8 (16.0) |
| eGFR category (ml/min/1.73 m2), n (%) | ||
| <25 | 10 (3.7) | 44 (3.3) |
| 25–<45 | 142 (53.2) | 642 (48.7) |
| 45–<60 | 64 (24.0) | 334 (25.4) |
| ≥60 | 47 (17.6) | 279 (21.2) |
| UACR (mg/g), median (IQR) | 871.9 (619.2–1409.1) | 808.3 (566.6–1218.5) |
| UACR category (mg/g), n (%) | ||
| <300 | 6 (2.2) | 57 (4.3) |
| 300–≤1000 | 148 (55.4) | 781 (59.3) |
| >1000 | 113 (42.3) | 479 (36.4) |
| . | Receiving an SGLT2 inhibitor at baseline . | |
|---|---|---|
| Characteristics . | Yes (n = 267) . | No (n = 1317) . |
| eGFR (ml/min/1.73 m2), mean (SD) | 45.6 (15.7) | 46.8 (16.0) |
| eGFR category (ml/min/1.73 m2), n (%) | ||
| <25 | 10 (3.7) | 44 (3.3) |
| 25–<45 | 142 (53.2) | 642 (48.7) |
| 45–<60 | 64 (24.0) | 334 (25.4) |
| ≥60 | 47 (17.6) | 279 (21.2) |
| UACR (mg/g), median (IQR) | 871.9 (619.2–1409.1) | 808.3 (566.6–1218.5) |
| UACR category (mg/g), n (%) | ||
| <300 | 6 (2.2) | 57 (4.3) |
| 300–≤1000 | 148 (55.4) | 781 (59.3) |
| >1000 | 113 (42.3) | 479 (36.4) |
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.
